Fairfield, Bush & Co.
- SEC CIK
- 0001116247
- Latest filing
- Aug 13, 2026
GMED holding history
Globus Medical Inc in every 13F filed by Fairfield, Bush & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GMED overviewAll 13F holders of GMEDFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −3,750−100.0% | Sold out | Holders |
| Q2 2024 | 3,750 | $256.8K | 0.2% | −300−7.4% | Reduced | Holders |
| Q1 2024 | 4,050 | $217.2K | 0.1% | −140−3.3% | Reduced | Holders |
| Q4 2023 | 4,190 | $223.3K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 4,190 | $208.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 4,190 | $249.5K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 4,190 | $237.3K | 0.1% | −250−5.6% | Reduced | Holders |
| Q4 2022 | 4,440 | $329.8K | 0.2% | −200−4.3% | Reduced | Holders |
| Q3 2022 | 4,640 | $276.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2022 | 4,640 | $260.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2022 | 4,640 | $342.0K | 0.2% | −1,040−18.3% | Reduced | Holders |
| Q4 2021 | 5,680 | $410.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2021 | 5,680 | $435.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 5,680 | $440.0K | 0.1% | −500−8.1% | Reduced | Holders |
| Q1 2021 | 6,180 | $381.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.